Upgrade to SI Premium - Free Trial

Neogenomics (NEO) PT Lowered to $18 at Jefferies

February 18, 2025 4:19 PM
Jefferies analyst Tycho Peterson lowered the price target on Neogenomics (NASDAQ: NEO) to $18.00 (from $22.00) while maintaining a Buy rating.

Categories

Analyst PT Change

Next Articles